Guidance for Market Authorization Holders on Post-Marketing Safety Reporting for Human Drugs,Narcotics, and Medicinal Neuropsychotropic Substances

Guidance for Market Authorization Holders on Post-Marketing Safety Reporting for Human Drugs,Narcotics, and Medicinal Neuropsychotropic Substances

สมัครรับข้อมูลข่าวสาร
RSS
สถิติผู้เข้าชม 64
TH EN